# COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)

> **NCT06062277** · PHASE2 · UNKNOWN · sponsor: **University College Dublin** · enrollment: 91 (estimated)

## Conditions studied

- Ischemic Stroke
- Atherosclerosis

## Interventions

- **DRUG:** Colchicine 0.5 MG

## Key facts

- **NCT ID:** NCT06062277
- **Lead sponsor:** University College Dublin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10
- **Primary completion:** 2024-10
- **Final completion:** 2025-06
- **Target enrollment:** 91 (ESTIMATED)
- **Last updated:** 2023-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06062277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06062277, "COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06062277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*